China Universal Asset Management Company’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Buy |
59,949
+178
| +0.3% | +$611 | 0.02% | 308 |
|
|
2025
Q1 | $133K | Sell |
59,771
-2,858
| -5% | -$6.37K | 0.01% | 343 |
|
|
2024
Q4 | $184K | Buy |
62,629
+5,955
| +11% | +$17.4K | 0.02% | 334 |
|
|
2024
Q3 | $147K | Buy |
56,674
+22,128
| +64% | +$57.5K | 0.02% | 323 |
|
|
2024
Q2 | $102K | Sell |
34,546
-21,760
| -39% | -$64.4K | 0.01% | 300 |
|
|
2024
Q1 | $255K | Buy |
56,306
+22,740
| +68% | +$103K | 0.03% | 263 |
|
|
2023
Q4 | $192K | Buy |
33,566
+26,143
| +352% | +$149K | 0.04% | 210 |
|
|
2023
Q3 | $34.1K | Buy |
7,423
+3,638
| +96% | +$16.7K | 0.01% | 255 |
|
|
2023
Q2 | $24.5K | Sell |
3,785
-113
| -3% | -$730 | 0.01% | 248 |
|
|
2023
Q1 | $29.4K | Buy |
3,898
+992
| +34% | +$7.48K | 0.01% | 185 |
|
|
2022
Q4 | $29.4K | Buy |
2,906
+236
| +9% | +$2.39K | 0.01% | 156 |
|
|
2022
Q3 | $26K | Buy |
+2,670
| New | +$26K | 0.01% | 142 |
|